Foley
& Lardner will be offering a web conference entitled "The Supreme
Court Decision(s) in Myriad: What Did
the Justices Say? What Does It Mean for Industry?" on June 26, 2013 from 12:00
to 1:15 pm (Eastern). Featured panelists
for the web conference will include The Honorable Paul R. Michel (ret.), U.S
Court of Appeals for the Federal Circuit; Dr. Hans Sauer, Associate General
Counsel for Intellectual Property for the Biotechnology Industry Organization;
and Patent Docs author Dr. Kevin
Noonan of McDonnell Boehnen Hulbert & Berghoff LLP. The web conferenced will be moderated by
Courtenay C. Brinckerhoff and hosted by Harold C. Wegner of Foley & Lardner. The panel will discuss the intricacies and likely impact of the Supreme
Court's decision in Association for Molecular Pathology v. Myriad Genetics,
Inc., as well as analyze
the decision and discuss what it means for the life sciences industry and the
evolving area of patent-eligibility jurisprudence as a whole.
While there is no cost to participate in the
program, pre-registration is required. Those
interested in attending the webinar can register here.
Comments